Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

across timeframes showed that thrombectomy, with or without thrombolysis, improved functional outcome as measured by the modified Rankin Scale (mRS) in people last known to be well up to 24 hours previously, compared with usual care. There was also a potential benefit for improved quality of life. However, there was no clinical difference in mortality and there were low rates of symptomatic intracerebral haemorrhage. The committee noted there had been some procedural complications associated with thrombectomy, but agreed that these were outweighed by the benefits of improvement in functional outcome. The committee looked at the results of 2 published costâ€“utility analyses with a UK NHS perspective. The first estimated that thrombectomy alongside intravenous thrombolysis (when appropriate) is cost effective compared with intravenous thrombolysis alone, when performed within 6 hours of stroke onset (that is, from when a person was last known to be well). The second demonstrated the cost effectiveness of thrombectomy therapy and best medical therapy compared with best medical therapy alone, when performed 6 to 24 hours after stroke onset. Therefore, the committee agreed to recommend thrombectomy up to 24 hours after stroke onset, together with intravenous thrombolysis if within the licensed time window, for people with appropriate
